Skip to content
sulfasalazine

Structure via PubChem · Public domain (PubChem)

EntityQ420035· pop 35· linked from 249 articles

sulfasalazine

Sign in to save

Also known as Azulfidine®, Salazopyridin®, Salazopyrin®, SAS-500, Salicylazosulfapyridine, Salazosulfapyridine, 5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid, 5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid

Sulfasalazine, sold under the brand name Azulfidine among others, is a medication used to treat rheumatoid arthritis, ulcerative colitis, and Crohn's disease. It is considered by some to be a first-line treatment in rheumatoid arthritis. It is taken by mouth or can be administered rectally.

Chemical data

Formula
C18H14N4O5S
Molecular weight
398.4 g/mol
IUPAC name
(3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid
SMILES
C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C/3\C=CC(=O)C(=C3)C(=O)O
InChIKey
OQANPHBRHBJGNZ-FYJGNVAPSA-N
XLogP
2.3
Polar surface area
146 Ų
H-bond donors
3
H-bond acceptors
9
Formal charge
0

via PubChem

~6 min read

Encyclopedic overview

7 sections
Contents
  • Medical uses
  • Side effects
  • Pharmacology
  • Chemistry
  • Cost
  • Research
  • References

{{Drugbox | Verifiedfields = changed | verifiedrevid = 460764435 | image = Sulfasalazine.svg | image_class = skin-invert-image | alt =

| tradename = Azulfidine, Salazopyrin, Sulazine, others | Drugs.com = | MedlinePlus = a682204 | DailyMedID = Sulfasalazine | pregnancy_AU = A | pregnancy_AU_comment = | pregnancy_category= | routes_of_administration = By mouth | class = Sulfonamides | ATC_prefix = A07 | ATC_suffix = EC01

Excerpted from Wikipedia’s “sulfasalazine” article, available under the CC BY-SA 4.0 licence.